LianBio
About:
LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.
Website: https://www.lianbio.com/
Top Investors: BlackRock, Pfizer, RA Capital Management, Perceptive Advisors, T. Rowe Price
Description:
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics.
$310M
$10M to $50M
Shanghai, Shanghai, China
2019-01-01
IR(AT)LianBio.com
Konstantin Poukalov
101-250
2020-10-29
Public
© 2025 bioDAO.ai